Susquehanna International Group, LLP Talaris Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.68 - $3.22 $36,544 - $43,907	-13,636 Reduced 42.54%	18,418 $51,000
Q2 2023 Aug 11, 2023	BUY	$1.78 - $3.2 $31,429 - $56,502	17,657 Added 122.64%	32,054 $97,000
Q1 2023 May 16, 2023	BUY	$1.09 - $2.09 $15,692 - $30,089	14,397 New	14,397 $27,000
Q2 2022 Aug 15, 2022	SELL	$4.51 - $9.85 $77,635 - $169,557	-17,214 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.89 - $16.56 $118,604 - $285,063	17,214 New	17,214 $169,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.